APP and Alzheimer disease: Accordingly, increased plasma soluble VE‐Cadherin was observed in AD and MCI patients, as well as in APP‐Tg mice (21 months), which may also indicate disassembly of VE‐Cadherin and loss of VE‐cadherin in brain vessels [105].